Cargando…

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)

Background: Cross-sectional studies have identified that the prevalence of neuropsychiatric symptoms (NPS) in Parkinson’s disease (PD) ranges from 70–89%. However, there are few longitudinal studies determining the impact of NPS on quality of life (QoL) in PD patients and their caregivers. We seek t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dlay, J. K., Duncan, G. W., Khoo, T. K., Williams-Gray, C. H., Breen, D. P., Barker, R. A., Burn, D. J., Lawson, R. A., Yarnall, A. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071603/ https://www.ncbi.nlm.nih.gov/pubmed/32024222 http://dx.doi.org/10.3390/brainsci10020078

Ejemplares similares

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)
por: Williams‐Gray, Caroline H., et al.
Publicado: (2016)

Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PD
por: Naisby, J., et al.
Publicado: (2021)

Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort
por: Lawson, Rachael A., et al.
Publicado: (2021)

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Mak, Elijah, et al.
Publicado: (2015)

Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study
por: Martin-Ruiz, Carmen, et al.
Publicado: (2020)

Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Nombela, Cristina, et al.
Publicado: (2014)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
por: Lawson, Rachael A., et al.
Publicado: (2016)

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease
por: Dissanayaka, Nadeeka N.W., et al.
Publicado: (2017)

Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
por: Lawson, Rachael A., et al.
Publicado: (2014)

Prevalence and duration of non‐motor symptoms in prodromal Parkinson's disease
por: Durcan, R., et al.
Publicado: (2019)

Snowballs and Icicles in Susac’s Syndrome
por: Dierickx, Jesper, et al.
Publicado: (2021)

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2019)

Cognitive impairment in Parkinson's disease: impact on quality of life of carers
por: Lawson, RA, et al.
Publicado: (2016)

The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2017)

Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson’s Disease
por: Morris, Rosie, et al.
Publicado: (2017)

Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology
por: Wilson, Joanna, et al.
Publicado: (2020)

Identifying delirium in Parkinson disease: A pilot study
por: Lawson, Rachael A., et al.
Publicado: (2020)

Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease
por: Mak, Elijah, et al.
Publicado: (2017)

Factors Influencing Habitual Physical Activity in Parkinson’s Disease: Considering the Psychosocial State and Wellbeing of People with Parkinson’s and Their Carers
por: Mc Ardle, Ríona, et al.
Publicado: (2022)

Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease
por: Wilson, Joanna, et al.
Publicado: (2020)

Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
por: Weintraub, Daniel, et al.
Publicado: (2020)

Natural history of falls in an incident cohort of Parkinson’s disease: early evolution, risk and protective features
por: Lord, Sue, et al.
Publicado: (2017)

Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s Disease
por: Lord, Sue, et al.
Publicado: (2014)

Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease
por: Ray, Nicola J, et al.
Publicado: (2022)

Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson’s disease
por: Carbutt, Sophia, et al.
Publicado: (2015)

Early constipation predicts faster dementia onset in Parkinson’s disease
por: Camacho, M., et al.
Publicado: (2021)

Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease
por: Pyle, Angela, et al.
Publicado: (2016)

Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease
por: Sigurdsson, Hilmar P., et al.
Publicado: (2022)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD
por: de la Fuente-Fernández, Raúl
Publicado: (2013)

The prevalence of sarcopenia in Parkinson’s disease and related disorders- a systematic review
por: Hart, Ashley, et al.
Publicado: (2023)

Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis
por: Landau, S., et al.
Publicado: (2016)

Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson's Disease Patients
por: Hidding, U., et al.
Publicado: (2017)

Neuropsychiatric Symptoms in an Inpatient Parkinson's Disease Sample
por: McLaughlin, Nicole C. R., et al.
Publicado: (2014)

Coping with Cognitive Impairment in People with Parkinson's Disease and Their Carers: A Qualitative Study
por: Lawson, Rachael A., et al.
Publicado: (2018)

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari, Szabolcs, et al.
Publicado: (2017)

Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
por: Breen, David P., et al.
Publicado: (2016)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

The challenge of neuropsychiatric manifestations in parkinson’s disease. A case report
por: Del Campo, A. Cerame, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ttn0rgb6o19t9j9ifukc5t165e